drugset / Trial / NCT01960205
Effect of Saxagliptin on Pre-Diabetes Mellitus and Obesity
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to examine the effect of Saxagliptin in the newly diagnosed people with pre-diabetes and obesity besides lifestyle intervention ,there to evaluate DPP 4 inhibitors of reversing pre-diabetes curative effect to normal blood sugar, and observe its influences on the targets of obesity related metabolic abnormalities, to explore new ways for intervention on populations with pre-diabetes and obesity .
Timeline
- Start
- 2013-08
- Primary completion
- 2014-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | 500 mg | — |
| Subject | SAXAGLIPTIN ANHYDROUS | Small molecule | 2.5 mg | — |
| Subject | SAXAGLIPTIN ANHYDROUS | Small molecule | 5 mg | — |